TB

Tomer Berkovitz

Managing Partner at aMoon Fund

Boston, Massachusetts

Overview

Work Experience

aF

aMoon Fund

  • Managing Partner

    2023 - Current

  • General Partner

    2018 - 2023

    aMoon is a global HealthTech & Life Sciences Investment Manager with >$1.3B AUM. Our investment platform includes three funds: early-stage (Velocity), late-stage (Growth) and public equity (Edge).

SG

SOPHiA GENETICS

  • Board Member

    2020

    NASDAQ: SOPH

AI

AltruBio Inc.

  • Board Member

    2024

PI

PrognomiQ Inc

  • Board Member

    2020

CH

Connie Health

  • Board Member

    2023

OH

Omada Health

  • Board Observer

    2021

ZM

Zebra Medical Vision Ltd

  • Board Member

    2018 - 2021

    Acquired by Nanox (NASDAQ: NNOX)

S

Seer

  • Board Observer

    2019 - 2020

    NASDAQ: SEER

A

Alcobra

  • COO & CFO

    2014 - 2018

    NASDAQ-traded biopharmaceutical company, merged with Arcturus Therapeutics (NASDAQ: ARCT)

J

JPMorgan

  • Executive Director, Investment Banking

    2012 - 2014

  • Vice President, Investment Banking

    2010 - 2011

  • Associate, Investment Banking

    2008 - 2009

Education

Investments

PrognomiQ

Series Unknown

Total Funding: $100M

Omada Health

Series E

Total Funding: $270M

Sera Prognostics

Series E

Total Funding: $140M

SOPHiA GENETICS

Series F

Total Funding: $220M

Relevant Websites